Search

Search Constraints

You searched for: Author/Creator Garre, Ana

Search Results

1. Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg). Issue 5 (13th July 2020)

2. Differences between childhood‐ and adulthood‐onset inflammatory bowel disease: the CAROUSEL study from GETECCU. Issue 4 (13th January 2019)

3. Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry. (16th April 2021)

4. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain. (May 2019)

5. Helicobacter pylori first‐line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp‐EuReg). Issue 3 (16th March 2020)

6. Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg). Issue 2 (5th February 2022)

7. Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg). Issue 2 (February 2022)

8. Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry. Issue 8 (3rd October 2018)

9. Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry. Issue 8 (3rd October 2018)

10. Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry. (24th September 2020)